O'Neill MJ - Search Results

1

An AMPA receptor potentiator modulates hippocampal expression of BDNF: an in vivo study.

Mackowiak M, O'Neill MJ, Hicks CA, Bleakman D, Skolnick P. Mackowiak M, et al. Neuropharmacology. 2002 Jul;43(1):1-10. doi: 10.1016/s0028-3908(02)00066-7. Neuropharmacology. 2002. PMID: 12213254

2

AMPA receptor potentiators for the treatment of CNS disorders.

O'Neill MJ, Bleakman D, Zimmerman DM, Nisenbaum ES. O'Neill MJ, et al. Curr Drug Targets CNS Neurol Disord. 2004 Jun;3(3):181-94. doi: 10.2174/1568007043337508. Curr Drug Targets CNS Neurol Disord. 2004. PMID: 15180479 Review.

3

LY503430, a novel alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor potentiator with functional, neuroprotective and neurotrophic effects in rodent models of Parkinson's disease.

Murray TK, Whalley K, Robinson CS, Ward MA, Hicks CA, Lodge D, Vandergriff JL, Baumbarger P, Siuda E, Gates M, Ogden AM, Skolnick P, Zimmerman DM, Nisenbaum ES, Bleakman D, O'Neill MJ. Murray TK, et al. J Pharmacol Exp Ther. 2003 Aug;306(2):752-62. doi: 10.1124/jpet.103.049445. Epub 2003 May 2. J Pharmacol Exp Ther. 2003. PMID: 12730350

4

Neurotrophic actions of the novel AMPA receptor potentiator, LY404187, in rodent models of Parkinson's disease.

O'Neill MJ, Murray TK, Whalley K, Ward MA, Hicks CA, Woodhouse S, Osborne DJ, Skolnick P. O'Neill MJ, et al. Eur J Pharmacol. 2004 Feb 20;486(2):163-74. doi: 10.1016/j.ejphar.2003.12.023. Eur J Pharmacol. 2004. PMID: 14975705

5

Decahydroisoquinolines: novel competitive AMPA/kainate antagonists with neuroprotective effects in global cerebral ischaemia.

O'Neill MJ, Bond A, Ornstein PL, Ward MA, Hicks CA, Hoo K, Bleakman D, Lodge D. O'Neill MJ, et al. Neuropharmacology. 1998 Oct-Nov;37(10-11):1211-22. doi: 10.1016/s0028-3908(98)00134-8. Neuropharmacology. 1998. PMID: 9849659

6

Stereoselective effects-of 2,3-benzodiazepines in vivo: electrophysiology and neuroprotection studies.

Lodge D, Bond A, O'Neill MJ, Hicks CA, Jones MG. Lodge D, et al. Neuropharmacology. 1996;35(12):1681-8. doi: 10.1016/s0028-3908(96)00155-4. Neuropharmacology. 1996. PMID: 9076747

7

NMDA receptor antagonism, but not AMPA receptor antagonism attenuates induced ischaemic tolerance in the gerbil hippocampus.

Bond A, Lodge D, Hicks CA, Ward MA, O'Neill MJ. Bond A, et al. Eur J Pharmacol. 1999 Sep 10;380(2-3):91-9. doi: 10.1016/s0014-2999(99)00523-3. Eur J Pharmacol. 1999. PMID: 10513567

8

LY377770, a novel iGlu5 kainate receptor antagonist with neuroprotective effects in global and focal cerebral ischaemia.

O'Neill MJ, Bogaert L, Hicks CA, Bond A, Ward MA, Ebinger G, Ornstein PL, Michotte Y, Lodge D. O'Neill MJ, et al. Neuropharmacology. 2000 Jul 10;39(9):1575-88. doi: 10.1016/s0028-3908(99)00250-6. Neuropharmacology. 2000. PMID: 10854902

9

Neuroprotective effects of LY379268, a selective mGlu2/3 receptor agonist: investigations into possible mechanism of action in vivo.

Bond A, Jones NM, Hicks CA, Whiffin GM, Ward MA, O'Neill MF, Kingston AE, Monn JA, Ornstein PL, Schoepp DD, Lodge D, O'Neill MJ. Bond A, et al. J Pharmacol Exp Ther. 2000 Sep;294(3):800-9. J Pharmacol Exp Ther. 2000. PMID: 10945827

10

The effects of ifenprodil and eliprodil on voltage-dependent Ca2+ channels and in gerbil global cerebral ischaemia.

Bath CP, Farrell LN, Gilmore J, Ward MA, Hicks CA, O'Neill MJ, Bleakman D. Bath CP, et al. Eur J Pharmacol. 1996 Mar 28;299(1-3):103-12. doi: 10.1016/0014-2999(95)00846-2. Eur J Pharmacol. 1996. PMID: 8901012

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

279 results

Search Page

Filters